Advertisement - Members don't see this ad
Some of my Urologists approached me recently about the idea of implanting the UroLift system prior to prostate EBRT for patients with pretreatment obstructive symptoms, with the idea that the metal components of the implants could serve as fiducials for IRGT in lieu of standard gold fiducial placement. Of course I said "what an excellent idea, my gracious Referral Overlords", but in thinking about it there seems to be at least a theoretical concern that scatter from the metal could cause increased urethral dose since the metal component is right against the wall of the urethra. Anyone have any experience with this? The only literature I could find was a rigorous series of 7 patients; not enough to hang your hat on:
UroLift in Place of Fiducial Markers for Patients With Benign Prostatic Hyperplasia Undergoing External Beam Radiation Therapy. - PubMed - NCBI
UroLift | BPH Treatment | Enlarged Prostate Surgery
UroLift in Place of Fiducial Markers for Patients With Benign Prostatic Hyperplasia Undergoing External Beam Radiation Therapy. - PubMed - NCBI
UroLift | BPH Treatment | Enlarged Prostate Surgery